Market Overview Orphan drugs refer to pharmaceutical products developed specifically to treat rare medical conditions, also known as orphan diseases. In many regions, a rare disease is defined as one affecting fewer than 200,000 people. These drugs often cater to small patient populations, making them economically less attractive for traditional drug manufacturers. However, with governments...

Market Overview The scleral lens market is set to grow at a promising pace, backed by an upsurge in demand from individuals suffering from keratoconus, corneal ectasia, post-LASIK complications, and ocular surface diseases. These lenses are not just corrective but therapeutic in nature, offering a viable alternative where traditional soft lenses or spectacles fail to deliver comfort...